Lyme Disease (Borrelia Burgdoferi Igm) – Eia

1,500.00

Categories: ,

The Borrelia burgdorferi IgM – EIA is a blood test used to detect IgM antibodies against Borrelia burgdorferi, the bacteria responsible for Lyme disease. EIA (Enzyme Immunoassay) is a screening test that uses enzymes to detect the presence of specific antibodies in the blood. The presence of IgM antibodies typically indicates a recent or early-stage infection.

Enquiry Here

    Description

    Why It’s Done:
    This test is done to:
    • Diagnose Lyme disease in its early stages, especially within the first few weeks of symptom onset.
    • Identify the presence of a recent Borrelia infection, as IgM is the first antibody the body produces in response.
    • Investigate symptoms such as:
    o Bull’s-eye rash (erythema migrans)
    o Fever and chills
    o Fatigue
    o Muscle and joint aches
    o Neurological symptoms in later stages

    Preparation:
    • No special preparation (such as fasting) is needed.
    • Inform your doctor about:
    o Any current medications or immune-related conditions, as these may affect results.
    o Timing of symptoms—testing too early may result in a false negative, as IgM antibodies may take 1–2 weeks to appear.
    • If you’re being tested as part of a follow-up or two-tier testing (EIA followed by Western blot), your provider will guide you accordingly.